查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
胚胎着床前基因诊断市场报告：2030 年趋势、预测与竞争分析
市场调查报告书
商品编码
1356801

胚胎着床前基因诊断市场报告：2030 年趋势、预测与竞争分析

Preimplantation Genetics Diagnosis Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

胚胎着床前遗传学诊断的趋势和预测

到 2030 年，全球胚胎着床前基因诊断市场预计将达到 2 亿美元，2024 年至 2030 年年复合成长率为 10.7%。该市场的主要驱动因素是遗传疾病盛行率的上升、人们对遗传学在生殖医学中的作用的认识不断提高以及不孕治疗的技术进步。全球胚胎着床前基因诊断市场前景广阔，诊断实验室、医院和诊所市场蕴藏未来性。

胚胎着床前基因诊断市场洞察

  • Lucintel 预测，由于非整倍体筛检方法的采用增加以及市场上推出的新产品，非整倍体将在预测期内实现最高成长。
  • 由于患者入院人数增加、医疗基础设施改善以及该地区公立和私立医院的存在，医院可能仍是最大的细分市场。
  • 由于体外受精的采用率不断提高以及该地区人们对体外受精的认识不断增强，预计亚太地区将在预测期内实现最高的增长。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些，由于材料或产品替代导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球胚胎着床前基因诊断市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球胚胎着床前基因诊断市场趋势（2018-2023）与预测（2024-2030）
  • 按类型分類的全球胚胎着床前基因诊断市场
    • 染色体异常
    • 非整倍体
    • X相关疾病
    • 单基因疾病
    • HLA分型
    • 性别选择
    • 其他的
  • 按最终用途分類的全球胚胎着床前基因诊断市场
    • 诊断实验室
    • 医院
    • 诊所
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 全球胚胎着床前基因诊断市场（按地区）
  • 北美胚胎着床前基因诊断市场
  • 欧洲胚胎着床前基因诊断市场
  • 亚太地区胚胎着床前基因诊断市场
  • 其他区域胚胎着床前基因诊断市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 全球胚胎着床前基因诊断市场成长机会（按类型）
    • 按最终用途分類的全球胚胎着床前基因诊断市场的成长机会
    • 全球胚胎着床前基因诊断市场按地区成长机会
  • 全球胚胎着床前基因诊断市场的新趋势
  • 战略分析
    • 新产品开发
    • 全球胚胎着床前基因诊断市场的产能扩张
    • 全球胚胎着床前基因诊断市场的合併、收购与合资企业
    • 认证和许可

第7章主要企业概况

  • PerkinElmer Agilent Technologies
  • Cegat
  • Laboratory Corporation of America Holdings
  • Illumina
  • Invitae Corporation
  • Pacgenomics
  • Quest Diagnostics
  • Natera
  • Reproductive Genetic Innovations（RGI）
简介目录

Preimplantation Genetics Diagnosis Trends and Forecast

The future of the global preimplantation genetics diagnosis market looks promising with opportunities in the diagnostic laboratory, hospital, and clinic markets. The global preimplantation genetics diagnosis market is expected to reach an estimated $0.20 billion by 2030 with a CAGR of 10.7% from 2024 to 2030. The major drivers for this market are rising prevalence of genetic disorder, growing awareness about the role of genetics in reproductive health, and technological advancement in the fertility treatments.

A more than 150-page report is developed to help in your business decisions.

Preimplantation Genetics Diagnosis by Segment

The study includes a forecast for the global preimplantation genetics diagnosis by type, end use, and region.

Preimplantation Genetics Diagnosis Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Chromosomal Abnormalities
  • Aneuploidy
  • X-linked diseases
  • Single Gene Disorders
  • HLA Typing
  • Gender selection
  • Others

Preimplantation Genetics Diagnosis Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Diagnostic Laboratories
  • Hospitals
  • Clinics
  • Others

Preimplantation Genetics Diagnosis Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Preimplantation Genetics Diagnosis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies preimplantation genetics diagnosis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the preimplantation genetics diagnosis companies profiled in this report include-

  • Perkinelmer Agilent Technologies
  • Cegat
  • Laboratory Corporation Of America Holdings
  • Illumina
  • Invitae Corporation
  • Pacgenomics
  • Quest Diagnostics
  • Natera
  • Reproductive Genetic Innovations (Rgi)

Preimplantation Genetics Diagnosis Market Insights

  • Lucintel forecasts that aneuploidy is expected to witness highest growth over the forecast period due to the growing adoption of aneuploidy screening methods and the introduction of novel products into the market.
  • Hospitals will remain the largest segment due to increasing admissions of patients, improvement in healthcare infrastructure, and availability of public as well as private hospitals in the region.
  • APAC is expected to witness highest growth over the forecast period due to increasing adoption of IVF translates and growing awaeness levels among people in the region.

Features of the Global Preimplantation Genetics Diagnosis Market

  • Market Size Estimates: Preimplantation genetics diagnosis market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
  • Segmentation Analysis: Preimplantation genetics diagnosis market size by type, end use, and region. in terms of value ($B).
  • Regional Analysis: Preimplantation genetics diagnosis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different types, end uses, and region.s for the preimplantation genetics diagnosis market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the preimplantation genetics diagnosis market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the preimplantation genetics diagnosis market size?

Answer: The global preimplantation genetics diagnosis market is expected to reach an estimated $0.20 billion by 2030.

Q.2. What is the growth forecast for preimplantation genetics diagnosis market?

Answer: The global preimplantation genetics diagnosis market is expected to grow with a CAGR of 10.7% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the preimplantation genetics diagnosis market?

Answer: The major drivers for this market are rising prevalence of genetic disorder, growing awareness about the role of genetics in reproductive health, and technological advancement in the fertility treatments.

Q.4. What are the major segments for preimplantation genetics diagnosis market?

Answer: The future of the preimplantation genetics diagnosis market looks promising with opportunities in the diagnostic laboratory, hospital, and clinic markets.

Q.5. Who are the key Preimplantation Genetics Diagnosis Market companies?

Answer: Some of the key preimplantation genetics diagnosis companies are as follows:

  • PerkinElmer Agilent Technologies
  • Cegat
  • Laboratory Corporation of America Holdings
  • Illumina
  • Invitae Corporation
  • Pacgenomics
  • Quest Diagnostics
  • Natera
  • Reproductive Genetic Innovations (RGI)

Q.6. Which preimplantation genetics diagnosis market segment will be the largest in future?

Answer: Lucintel forecasts that aneuploidy is expected to witness highest growth over the forecast period due to the growing adoption of aneuploidy screening methods and the introduction of novel products into the market.

Q.7. In preimplantation genetics diagnosis market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to increasing adoption of IVF translates and growing awaeness levels among people in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the preimplantation genetics diagnosis market by type (chromosomal abnormalities, aneuploidy, X-linked diseases,single gene disorders, HLA typing, gender selection, and others), end use (diagnostic laboratories, hospitals, clinics, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Preimplantation Genetics Diagnosis Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Preimplantation Genetics Diagnosis Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Preimplantation Genetics Diagnosis Market by Type
    • 3.3.1: Chromosomal Abnormalities
    • 3.3.2: Aneuploidy
    • 3.3.3: X-linked Diseases
    • 3.3.4: Single Gene Disorders
    • 3.3.5: HLA Typing
    • 3.3.6: Gender Selection
    • 3.3.7: Others
  • 3.4: Global Preimplantation Genetics Diagnosis Market by End Use
    • 3.4.1: Diagnostic Laboratories
    • 3.4.2: Hospitals
    • 3.4.3: Clinics
    • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Preimplantation Genetics Diagnosis Market by Region
  • 4.2: North American Preimplantation Genetics Diagnosis Market
    • 4.2.2: North American Preimplantation Genetics Diagnosis Market by End Use: Diagnostic Laboratories, Hospitals, Clinics, and Others
  • 4.3: European Preimplantation Genetics Diagnosis Market
    • 4.3.1: European Preimplantation Genetics Diagnosis Market by Type: Chromosomal Abnormalities, Aneuploidy, X-linked diseases, Single Gene Disorders, HLA Typing, Gender Selection, and Others
    • 4.3.2: European Preimplantation Genetics Diagnosis Market by End Use: Diagnostic Laboratories, Hospitals, Clinics, and Others
  • 4.4: APAC Preimplantation Genetics Diagnosis Market
    • 4.4.1: APAC Preimplantation Genetics Diagnosis Market by Type: Chromosomal Abnormalities, Aneuploidy, X-linked diseases, Single Gene Disorders, HLA Typing, Gender Selection, and Others
    • 4.4.2: APAC Preimplantation Genetics Diagnosis Market by End Use: Diagnostic Laboratories, Hospitals, Clinics, and Others
  • 4.5: ROW Preimplantation Genetics Diagnosis Market
    • 4.5.1: ROW Preimplantation Genetics Diagnosis Market by Type: Chromosomal Abnormalities, Aneuploidy, X-linked diseases, Single Gene Disorders, HLA Typing, Gender Selection, and Others
    • 4.5.2: ROW Preimplantation Genetics Diagnosis Market by End Use: Diagnostic Laboratories, Hospitals, Clinics, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Preimplantation Genetics Diagnosis Market by Type
    • 6.1.2: Growth Opportunities for the Global Preimplantation Genetics Diagnosis Market by End Use
    • 6.1.3: Growth Opportunities for the Global Preimplantation Genetics Diagnosis Market by Region
  • 6.2: Emerging Trends in the Global Preimplantation Genetics Diagnosis Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Preimplantation Genetics Diagnosis Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Preimplantation Genetics Diagnosis Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: PerkinElmer Agilent Technologies
  • 7.2: Cegat
  • 7.3: Laboratory Corporation of America Holdings
  • 7.4: Illumina
  • 7.5: Invitae Corporation
  • 7.6: Pacgenomics
  • 7.7: Quest Diagnostics
  • 7.8: Natera
  • 7.9: Reproductive Genetic Innovations (RGI)